Skip to content

The Effect of Feeding Infant Formula With Enriched Protein Fractions

The Effect of Feeding Infant Formula With Enriched Protein Fractions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02274883
Enrollment
451
Registered
2014-10-24
Start date
2014-11-30
Completion date
2017-05-31
Last updated
2017-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Ability, General

Brief summary

This study is intended to evaluate the nutritive effects of study formulas on growth and cognitive outcomes.

Detailed description

To evaluate the nutritive effects of study formulas on growth and cognitive outcomes.

Interventions

DIETARY_SUPPLEMENTEnriched Protein Fractions

Enriched protein fractions

DIETARY_SUPPLEMENTProtein Fractions

Protein fractions

Sponsors

Shanghai Children's Medical Center
CollaboratorOTHER
Mead Johnson Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
10 Days to 14 Days
Healthy volunteers
Yes

Inclusion criteria

* 10-14 days of age * Exclusively formula-fed * Singleton birth * Gestational age of 37-42 weeks * Birth weight of 2500g to 4000g * Signed Informed Consent Form

Exclusion criteria

* History of underlying metabolic or chronic disease * Congenital malformation * Condition which is likely to interfere with food ingestion, normal growth, development and evaluation * Evidence of feeding difficulties or intolerance * Immunocompromised * Head/brain disease/injury

Design outcomes

Primary

MeasureTime frameDescription
Infant cognitive developmentAt 12 months of ageCognitive Scale of Bayley-III is used as the assessment tool.

Secondary

MeasureTime frameDescription
Infant language and motor skillsAt 4, 6, 9, 12 and 18 months of ageAges and Stages Questionnaire, MacArthur-Bates Communicative Development Index, Language Scale and Motor Scale of Bayley-III are used as the assessment tool.
Infant acquisition of social and emotional milestones and adaptive developmentAt 4, 6, 9, 12 and 18 months of ageAges and Stages Questionnaire, social-emotional scale and adaptive behavior scale of Bayley-III are used as assessment tool.
Infant temperamentAt 12 and 18 months of ageCarey Scale is used as assessment tool.
Infant attention capabilitiesAt 12 and 18 months of ageSingle Object Attention and Free Play Tasks is used as assessment tool.
Infant cognitive developmentAt 18 months of ageCognitive Scale of Bayley-III is used as the assessment tool.
Stool characteristicsAt 14, 30, 42, 60, 90, 120, 180, 275 and 365 days of ageAccording to the recall of parents during the last 24 hours.
Formula intakeAt 30, 42, 60, 90, 120, 180, 275 and 365 days of ageAccording to the recall of parents during the last 24 hours.
Fecal microbiome and metabolome profileAverage of 14 days of age and 120 days of ageFecal microbiome analysis is done at average of 14 days and 120 days of age. While metabolome profile analysis is done at only average of 120 days of age.
Medically-confirmed Adverse EventsUp to 19 months of age
Physical developmentAt 14, 30, 42, 60, 90, 120, 180, 275, 365, and 545 days of ageBody weight, length and head circumference are measured.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026